Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07737665Phase 4Recruiting
Phase 4, randomised, double-blind trial in sleep disorders comparing Melatonin with Placebo (2 arms). Primary endpoint: Pittsburgh Sleep Quality Index at 12 weeks. Started Apr 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07737665.